Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise

Abstract

Introduction Our group has completed an exercise study of 200 patients with mild Alzheimer's disease. We found improvements in cognitive, neuropsychiatric, and physical measures in the participants who adhered to the protocol. Epidemiological studies in healthy elderly suggest that exercise preserves cognitive and physical abilities to a higher extent in AP OE ε4 carriers. Methods In this post hoc subgroup analysis study, we investigated whether the beneficial effect of an exercise intervention in patients with mild AD was dependent on the patients' APOE genotype. Results We found that patients who were APOE ε4 carriers benefitted more from the exercise intervention by preservation of cognitive performance and improvement in physical measures. Discussion This exploratory study establishes a possible connection between the beneficial effects of exercise in AD and the patients' APOE genotype. These findings, if validated, could greatly impact the clinical management of patients with AD and those at risk for developing AD.

Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer’s Disease

“…On the contrary, carriers of APOE ε4 showed less modulation of the lipid profile after exercise when compared to ε4 non-carriers. This is somewhat surprising as the same cohort of APOE ε4 carriers benefitted the most from exercise regarding physical outcomes such as walking speed, endurance, and overall fitness (Jensen et al, 2019). Still, it must be stressed that none of these results are statistically significant, and that the number of patients who were ε4/ε4 carriers was low.…”

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

“…However, this study did not report how many of these sedentary APOE4 carriers went on to develop actual AD-type dementia. A more recent study with 200 individuals diagnosed with mild AD addressed this issue, examining if exercise held any cognitive or physical improvements for APOE4 carriers [175]. The data did support that exercise intervention improved cognitive function, and was found to be more beneficial to APOE4 carriers.…”

Nonpharmacological treatment options for Alzheimer’s disease: from animal testing to clinical studies

“…The APOE ε4 allele is considered as the most significant genetic risk factor that may lead to vascular damage and impaired cholesterol transport. A recent study revealed that APOE ε4 allele-carrying patients benefitted more from PA intervention than noncarriers in terms of cognitive and neuropsychiatric functions as well as physical measures (Jensen et al, 2019b). The second is associated with the modulation of neuroinflammation in AD.…”